Moderna says FDA delayed RSV vaccine approval to end of May
The FDA has not informed Moderna of any issues related to the vaccine's safety, efficacy or quality that would prevent
Read MoreThe FDA has not informed Moderna of any issues related to the vaccine's safety, efficacy or quality that would prevent
Read MoreThe deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having
Read MoreAmgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are progressing on their own treatments. Source link
Read MoreAmgen's update fueled concerns about potential new competition in the weight loss drug market, sending shares of Novo Nordisk and
Read MoreAmgen is among several drugmakers racing to join the red-hot weight loss drug space dominated by Novo Nordisk and Eli
Read MoreAmong the company's investments to "transform" its specialty pharmacy services is the opening of a new facility dedicated to cell
Read MoreRoche lowered its 2024 growth outlook in February as it continues to confront a drop-off in demand for its Covid-19
Read MoreShares of Swiss drugmaker Novartis climbed as much as 4.8% in early deals Tuesday after it raised its full-year guidance
Read MoreThe findings add to concerns that GLP-1s could take a bite out of the bottom lines of some of the
Read More